Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology

  title={Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology},
  author={Katia Pauwels and Ruth Mampuys and Catherine Golstein and Didier Breyer and Philippe Herman and Marion Kaspari and Jean Christophe Pag{\`e}s and Herbert Pfister and Frank van der Wilk and Birgit Sch{\"o}nig},
  journal={Journal f{\"u}r Verbraucherschutz und Lebensmittelsicherheit},
In Europe and beyond, several advisory bodies have been monitoring the developments in the field of Synthetic Biology. Reports have been sent to national governments for information on the developments and possible regulatory and risk assessment questions raised by this field. To put the issues in a broader perspective, four national biosafety advisory bodies (the French High Council for Biotechnology, the German Central Committee on Biological Safety, the Netherlands Commission on Genetic… 
Opportunities, Challenges, and Future Considerations for Top-Down Governance for Biosecurity and Synthetic Biology
Although potentially enabling tremendous opportunities for the advancement of the global bio economy, opening new avenues for the creation of health, wealth and environmental sustainability, the possibility of a more ‘democratic’ (widely accessible) bioengineering capability could equally yield new opportunities for accidental, unintended or deliberate misuse.
Bridging gaps in synthetic biology oversight : iGEM as a testbed for proactive, adaptive risk management
This thesis will argue that the current approach of relying on prescriptive, sequence-based controls creates growing gaps in oversight for a field moving toward amalgam organisms, and that the soft methods intended to bridge these gaps are instead points of additional significant vulnerability.
Chapter 3 Opportunities , Challenges , and Future Considerations for Top-Down Governance for Biosecurity and Synthetic
Synthetic biology promises to make biology easier to engineer (Endy 2005), enabling more people in less formal research settings to participate in modern biology. Leveraging advances in DNA
Genetic frontiers for conservation: an assessment of synthetic biology and biodiversity conservation: technical assessment
In recent years synthetic biology has emerged as a suite of techniques and technologies that enable humans to read, interpret, modify, design and manufacture DNA in order to rapidly influence the
Emerging crossover technologies: How to organize a biotechnology that becomes mainstream?
This article highlights the overarching issues in biotechnology developments from a societal and regulatory perspective and recommendations are made on how to initiate responsible governance of a biotechnology that becomes mainstream.
Synthetic biology’s multiple dimensions of benefits and risks: implications for governance and policies
This work states that knowledge derived from systems biology, whole-genome engineering, pathway engineering, mathematical modeling and computer-aided design, as well as the notion of interchangeable ‘biological parts’ are often seen as hallmarks of the SB idea.
Estimating and Predicting Exposure to Products from Emerging Technologies
Risk is a common metric for public health and environmental decision-making. Scientifically, credible risk assessments underpin decisions regarding the potential safety of emerging technologies


The farther, the safer: a manifesto for securely navigating synthetic species away from the old living world
Chemical diversification of life forms could be designed to block metabolic cross-feed and genetic cross-talk between synthetic and wild species and hence protect natural habitats and human health through novel types of containment.
A retrosynthetic biology approach to metabolic pathway design for therapeutic production
This work presents a unified framework that integrates diverse techniques involved in the design of heterologous biosynthetic pathways through a retrosynthetic approach in the reaction signature space and enables the flexible design of industrial microorganisms for the efficient on-demand production of chemical compounds with therapeutic applications.
Synthetic biology and metabolic engineering.
This paper reviews the origins of the two fields and advances two distinct paradigms for each: that of unit operations for metabolic engineering and electronic circuits for synthetic biology.
Xenobiology: A new form of life as the ultimate biosafety tool
  • Markus Schmidt
  • Biology
    BioEssays : news and reviews in molecular, cellular and developmental biology
  • 2010
Why it is necessary to go ahead designing xenobiological systems like XNA and its XNA binding proteins; what the biosafety specifications should look like for this genetic enclave; which steps should be carried out to boot up the first XNA life form; and what it means for the society at large are discussed.
Live Attenuated Influenza Vaccines by Computer-Aided Rational Design
The previously described synthetic attenuated virus engineering (SAVE) approach to influenza virus strain A/PR/8/34 was applied to rationally design live attenuated influenza virus vaccine candidates through genome-scale changes in codon-pair bias.
A retrosynthetic biology approach to therapeutics: from conception to delivery.
Systems of creation: the emergence of life from nonliving matter.
  • S. Mann
  • Biology
    Accounts of chemical research
  • 2012
This Account reviews the key life criteria required for the development of protobiological systems and discusses recent advances in the design, chemical construction, and operation of protocell models based on self-assembled phospholipid or fatty acid vesicles, self-organized inorganic nanoparticles, or spontaneous microphase separation of peptide/nucleotide membrane-free droplets.
On the road towards chemically modified organisms endowed with a genetic firewall.
This is the first successful attempt to cross the canonical/noncanonical chemical barrier by artificially evolving bacteria with a chlorinated DNA genome by showing that T could be "transliterated" to its noncanonical analogue 5-chorouracil (c) in the genome of Escherichia coli.
Expanding the chemical palate of cells by combining systems biology and metabolic engineering.
Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome
The design, synthesis, and assembly of the 1.08–mega–base pair Mycoplasma mycoides JCVI-syn1.0 genome starting from digitized genome sequence information and its transplantation into a M. capricolum recipient cell to create new cells that are controlled only by the synthetic chromosome are reported.